Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Is genomic analysis possible in a tissue acquired via endoscopic ultrasound-guided fine-needle biopsy in cholangiocarcinoma?

  • Jonghyun Lee (Division of Gastroenterology, Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital) ;
  • Sung Yong Han (Division of Gastroenterology, Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital)
  • Received : 2024.02.16
  • Accepted : 2024.03.31
  • Published : 2024.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010;362:1273-1281. https://doi.org/10.1056/NEJMoa0908721
  2. Shroff RT, Guthrie KA, Scott AJ, et al. SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers. J Clin Oncol 2023;41(4_suppl):LBA490.
  3. Oh DY, He AR, Qin S, et al. A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1. J Clin Oncol 2022;40(4_suppl):378.
  4. Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023;401:1853-1865.
  5. Ozono Y, Kawakami H, Uchiyama N, et al. Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers. J Gastroenterol 2023;58:1081-1093. https://doi.org/10.1007/s00535-023-02037-z
  6. Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 2020;21:671-684. https://doi.org/10.1016/S1470-2045(20)30109-1
  7. Goyal L, Meric-Bernstam F, Hollebecque A, et al. Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma. N Engl J Med 2023;388:228-239. https://doi.org/10.1056/NEJMoa2206834
  8. De Moura DT, Moura EG, Bernardo WM, et al. Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: systematic review and meta-analysis. Endosc Ultrasound 2018;7:10-19. https://doi.org/10.4103/2303-9027.193597
  9. Hijioka S, Nagashio Y, Maruki Y, et al. Endoscopic ultrasound-guided tissue acquisition of pancreaticobiliary cancer aiming for a comprehensive genome profile. Diagnostics (Basel) 2023;13:1275.
  10. Yanaidani T, Hara K, Okuno N, et al. Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of patients with biliary tract cancer, especially with intrahepatic cholangiocarcinoma. Clin Endosc 2024;57:384-392. https://doi.org/10.5946/ce.2023.139
  11. Liu S, Cadoux-Hudson T, Schofield CJ. Isocitrate dehydrogenase variants in cancer: cellular consequences and therapeutic opportunities. Curr Opin Chem Biol 2020;57:122-134. https://doi.org/10.1016/j.cbpa.2020.06.012
  12. Neumann O, Burn TC, Allgauer M, et al. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Br J Cancer 2022;127:1540-1549. https://doi.org/10.1038/s41416-022-01908-1
  13. Ruiz-Cordero R, Ng DL. Neurotrophic receptor tyrosine kinase (NTRK) fusions and their role in cancer. Cancer Cytopathol 2020;128:775-779. https://doi.org/10.1002/cncy.22350
  14. McCain J. The MAPK (ERK) pathway: investigational combinations for the treatment of BRAF-mutated metastatic melanoma. P T 2013;38:96-108.
  15. Idossa D, Borrero M, Blaes A. ERBB2-low (also known as HER2-low) breast cancer. JAMA Oncol 2023;9:576.
  16. Saha D, Ryan KR, Lakkaniga NR, et al. Targeting rearranged during transfection in cancer: a perspective on small-molecule inhibitors and their clinical development. J Med Chem 2021;64:11747-11773. https://doi.org/10.1021/acs.jmedchem.0c02167
  17. Vidula N, Lipman A, Kato S, et al. Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer. NPJ Breast Cancer 2022;8:117.
  18. Lawlor RT, Mattiolo P, Mafficini A, et al. Tumor mutational burden as a potential biomarker for immunotherapy in pancreatic cancer: systematic review and still-open questions. Cancers (Basel) 2021;13:3119.